drugset / Trial / NCT04554615
Intensive Insulin Therapy as Therapeutic Strategy for Non-diabetic Hyperglycemia After Surgery in ICU
RandomizedParallel-groupDouble-blindTreatment
Summary
The current study hypothesizes that the use of Intravenous intensive insulin therapy (IV-IIT) may be beneficial than IV conventional insulin therapy (IV-CIT) for improving the outcome of non-diabetic surgical patients had postoperative (PO) stress hyperglycemia (PSH).
Timeline
- Start
- 2017-09-14
- Primary completion
- 2018-03-03
- Completion
- 2018-06-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Insulin | Protein / enzyme biologic | 0.001 iu/kg | Intravenous |
| Comparator | Insulin | Protein / enzyme biologic | 50 iu | Intravenous |